MAIA Biotechnology Inc. (MAIA)
MAIA trades on NYSE in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$1.16
-1.70% on the day
Market cap
$71.6M
Micro cap
Revenue · 2024
$0
Prior year not contiguous
Net income · 2024
-$23.3M
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2024.
Profile
| Field | Value |
|---|---|
| Ticker | MAIA on NYSE |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | Not reported by the screener |
| IPO year | 2022 |
| SEC CIK | 0001878313 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials · 2024
| Line | Value |
|---|---|
| Revenue | $0 |
| Net income | -$23.3M |
| Operating income | -$17.0M |
| Net margin | Needs revenue and net income |
| Operating margin | Operating income not reported |
| Revenue growth | No prior-year revenue to compare |
| Cash | $0 |
| Total assets | $10.2M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | Needs market cap and revenue |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B3 | 2026-10-07 |
| Latest annual report | 10-K | 2026-03-23 |
| Latest quarterly / interim | 10-Q | 2026-08-10 |
| Latest current report | 8-K | 2026-10-06 |
| Latest proxy | DEFA14A | 2026-05-19 |
Source: SEC EDGAR submissions feed, 503 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| ZYBT | Zhengye Biotechnology Holding Limited | $1.48 | -12.43% | $70.1M |
| HYFT | MindWalk Holdings Corp. | $1.48 | +5.71% | $69.7M |
| CTOR | Citius Oncology Inc. | $0.7920 | -2.54% | $73.6M |
| MNOV | Medicinova Inc | $1.50 | -2.60% | $73.8M |
| HRTX | Heron Therapeutics Inc. | $0.3906 | -6.01% | $74.2M |
| NMAD | Nomad Power Solutions Inc. | $4.28 | +2.64% | $68.9M |
| CING | Cingulate Inc. | $4.72 | -2.48% | $68.6M |
| LFVN | Lifevantage Corporation Common Stock (Delaware) | $5.95 | -0.50% | $74.9M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier